ArticlePharmaceuticals (Basel, Switzerland)2026
Design, Synthesis and Antihyperglycemic/Antilipidemic Activities of Quinoline-thiazolidine-2,4-dione Hybrid.
ElShimaa Ahmed Mohamed Abousaada, Asmaa Galal-Khallaf, Khaled Mohammed-Geba, Mohamed El-Bahnsawye, Mona K Abo Hussein, Elshaymaa I Elmongy, Rania Ali Ahmed Shaltout, Reem Binsuwaidan, Hadeer Ali, Ahmed I El-Tantawy and 2 more
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
ElShimaa Ahmed Mohamed AbousaadaChemistry Department, Faculty of Science, Menoufia University, Shebin El-Kom 32511, Egypt.
Asmaa Galal-KhallafZoology Department, Molecular Biology and Biotechnology Laboratory, Faculty of Science, Menoufia University, Shebin El-Kom 32511, Egypt.
Khaled Mohammed-GebaZoology Department, Molecular Biology and Biotechnology Laboratory, Faculty of Science, Menoufia University, Shebin El-Kom 32511, Egypt.
Mohamed El-BahnsawyeChemistry Department, Faculty of Science, Menoufia University, Shebin El-Kom 32511, Egypt.
Mona K Abo HusseinClinical Microbiology and Immunology Department, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt.
Elshaymaa I ElmongyPharmaceutical Chemistry Department, Faculty of Pharmacy, Capital University (Formerly Helwan University), Ain Helwan, Cairo 11795, Egypt.ORCID 0000-0003-1160-5040 Rania Ali Ahmed ShaltoutZoology Department, Molecular Biology and Biotechnology Laboratory, Faculty of Science, Menoufia University, Shebin El-Kom 32511, Egypt.
Reem BinsuwaidanDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0003-1406-282X Hadeer AliChemistry Department, Faculty of Science, Menoufia University, Shebin El-Kom 32511, Egypt.ORCID 0009-0002-9496-6086 Ahmed I El-TantawyResearch Institute for Interdisciplinary Science, Okayama University, Tsushima-naka, Kita-ku, Okayama 700-8530, Japan.ORCID 0000-0001-6826-8933 Hamed Abdel-BaryChemistry Department, Faculty of Science, Menoufia University, Shebin El-Kom 32511, Egypt.
Ibrahim El Tantawy El SayedChemistry Department, Faculty of Science, Menoufia University, Shebin El-Kom 32511, Egypt.ORCID 0000-0003-1227-7931 Funding
Princess Nourah bint Abdulrahman University Researchers Supporting Project (number PNURSP2026R304)
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
diabeteshybridhyperglycemichyperlipidemicquinolinethiazolidinedionezebrafish
What OpenQuestion holds
Textmetadata
Read underepoch 390